BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases

计划入组 200 人 · 首次发布于 2019 年 9 月 6 日

A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases

计划入组 10 人 · 首次发布于 2024 年 8 月 22 日

Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases

计划入组 30 人 · 首次发布于 2026 年 3 月 12 日

midkine mRNA program (breast cancer/liver cancer)

Breast cancer (BreakBio)

breast cancer vaccine

JAPAN BREAST CANCER RESEARCH GROUP

Japan

ANZ BREAST CANCER TRIALS GROUP LIMITED

Australia

International Breast Cancer Research Foundation

United States

Disitamab vedotin shows phase 3 benefit in HER2-positive breast cancer liver metastases

FDA Clears Delcath's HEPZATO for Phase 2 Trial in Liver-Dominant Metastatic Breast Cancer

Samuraciclib Shows Promise in HR+ Breast Cancer Patients Without TP53 Mutations or Liver Metastases